United States securities and exchange commission logo

                          August 14, 2023

       Berndt Modig
       Chief Executive Officer
       Pharvaris N.V.
       Emmy Noetherweg 2
       2333 BK Leiden

                                                        Re: Pharvaris N.V.
Statement on Form F-3
                                                            Filed August 7,
                                                            File No. 333-273757

       Dear Berndt Modig:

              This is to advise you that we have not reviewed and will not
review your registration

               Please refer to Rules 460 and 461 regarding requests for
acceleration. We remind you
       that the company and its management are responsible for the accuracy and
adequacy of their
       disclosures, notwithstanding any review, comments, action or absence of
action by the staff.

                                                        Please contact Doris
Stacey Gama at 202-551-3188 with any questions.


                          Division of Corporation Finance

                          Office of Life Sciences
       cc:                                              Jennifer Lee, Esq.